Mackey JR - Search Results

1

Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition.

Lewis CW, Bukhari AB, Xiao EJ, Choi WS, Smith JD, Homola E, Mackey JR, Campbell SD, Gamper AM, Chan GK. Lewis CW, et al. Among authors: mackey jr. Cancer Res. 2019 Dec 1;79(23):5971-5985. doi: 10.1158/0008-5472.CAN-19-1961. Epub 2019 Oct 8. Cancer Res. 2019. PMID: 31594837

2

Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA, Crawford CR, Cass CE. Mackey JR, et al. Cancer Res. 1998 Oct 1;58(19):4349-57. Cancer Res. 1998. PMID: 9766663

3

Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.

Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M, Koski SL, Coupland RW, Baldwin SA, Young JD, Cass CE. Mackey JR, et al. Clin Cancer Res. 2002 Jan;8(1):110-6. Clin Cancer Res. 2002. PMID: 11801546

4

The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

Clarke ML, Mackey JR, Baldwin SA, Young JD, Cass CE. Clarke ML, et al. Among authors: mackey jr. Cancer Treat Res. 2002;112:27-47. doi: 10.1007/978-1-4615-1173-1_2. Cancer Treat Res. 2002. PMID: 12481710 Review. No abstract available.

5

Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.

Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Aviel-Ronen S, Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T. Sève P, et al. Clin Cancer Res. 2007 Feb 1;13(3):994-9. doi: 10.1158/1078-0432.CCR-06-1503. Clin Cancer Res. 2007. PMID: 17289895 Clinical Trial.

6

Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

Damaraju VL, Bouffard DY, Wong CK, Clarke ML, Mackey JR, Leblond L, Cass CE, Grey M, Gourdeau H. Damaraju VL, et al. Among authors: mackey jr. BMC Cancer. 2007 Jul 3;7:121. doi: 10.1186/1471-2407-7-121. BMC Cancer. 2007. PMID: 17608948 Free PMC article.

7

Adjuvant targeted therapy in early breast cancer.

Mackey J, McLeod D, Ragaz J, Gelmon K, Verma S, Pritchard K, Laing K, Provencher L, Charbonneau LF. Mackey J, et al. Cancer. 2009 Mar 15;115(6):1154-68. doi: 10.1002/cncr.24114. Cancer. 2009. PMID: 19165856 Free article. Review.

8

Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer.

Lesniak D, Xu Y, Deschenes J, Lai R, Thoms J, Murray D, Gosh S, Mackey JR, Sabri S, Abdulkarim B. Lesniak D, et al. Among authors: mackey jr. Cancer Res. 2009 Nov 15;69(22):8620-8. doi: 10.1158/0008-5472.CAN-09-1591. Epub 2009 Nov 3. Cancer Res. 2009. PMID: 19887601

9

DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer.

Germain DR, Graham K, Glubrecht DD, Hugh JC, Mackey JR, Godbout R. Germain DR, et al. Among authors: mackey jr. Breast Cancer Res Treat. 2011 May;127(1):53-63. doi: 10.1007/s10549-010-0943-7. Epub 2010 May 25. Breast Cancer Res Treat. 2011. PMID: 20499159

10

Senescence evasion by MCF-7 human breast tumor-initiating cells.

Karimi-Busheri F, Rasouli-Nia A, Mackey JR, Weinfeld M. Karimi-Busheri F, et al. Among authors: mackey jr. Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2. Breast Cancer Res. 2010. PMID: 20525204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters